Abstract
Recent evidence has denied genetic abnormality as a mechanism of the C5 variant of butyrylcholinesterase (BChE) and proposed the binding of an unknown protein with the C4 component. The present study aimed to evaluate whether the coding sequences and nontranslated sequences of the BChE gene at exons 1 to 4, 3q are structurally different in subjects having elevated BChE with and without the C5 variant phenotype. We also attempted to identify the unknown protein associated with the C5 variant and measured the BChE-specific activity in the C5 variant with an enzyme-linked immunosorbent assay (ELISA) using anti-BChE monoclonal antibody. We investigated five subjects, four of whom had elevated plasma BChE (three C5-positive [C5(+)] and one C5-negative [C5(–)]) and one control with a normal plasma BChE level. Direct DNA sequencing of the BChE gene revealed no relevant genetic mutations and no abnormal migrations in the genes of all five subjects. Precipitation of the patients’ sera with anti-human immunoglobulin A (IgA), -IgG, -IgM, anti-human albumin antibodies had no effect on the BChE activity. The measured BChE activity in C5(+) was 30 to 54% higher than the activity calculated from BChE protein content. The present results suggest that the C5(+) phenotype is not associated with any genetic abnormality in the CHE1 locus, and BChE-specific activity is enhanced in the C5(+) variant. However, the exact nature of the unknown protein related to the C5(+) phenotype remains unclear.
References
1 Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989; 260:625–34.10.1042/bj2600625Search in Google Scholar
2 Prody CA, Zevin-Sonkin D, Gnatt A, Goldberg O, Soreq H. Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues. Proc Natl Acad Sci USA 1987; 84:3555–9.10.1073/pnas.84.11.3555Search in Google Scholar
3 Vellom DC, Radic Z, Li Y, Pickering NA, Camp S, Taylor P. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase. Biochemistry 1993; 32:12–17.10.1021/bi00052a003Search in Google Scholar
4 Lockridge O. Genetic variants of human serum cholinesterase Influence metabolism of the muscle relaxant succinylcholine. Pharmac Ther 1990; 47:35–60.10.1016/0163-7258(90)90044-3Search in Google Scholar
5 Masson P. A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. Biochim Biophys 1989; 988:258–66.10.1016/0167-4838(89)90282-3Search in Google Scholar
6 Harris H, Hopkinson DA, Robson EB, Whittaker M. Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann Hum Genet (Lond) 1963; 26:359–82.10.1111/j.1469-1809.1963.tb01335.xSearch in Google Scholar PubMed
7 Steegmüller H. On the geographical distribution of pseudocholinesterase variants. Humangenetik 1975; 26:167–85.10.1007/BF00281451Search in Google Scholar PubMed
8 Marazita ML, Keats BJ, Spence MA, Sparkes RS, Field LL, Sparkes MC, et al. Mapping studies of the serum cholinesterase-2 locus(CHE2). Hum Genet 1989; 83:139–44.10.1007/BF00286706Search in Google Scholar PubMed
9 Kidd KK, Gusella J. Report of the committee on the genetic constitution of chromosomes 3 and 4. J Cytogenet Cell Genet 1985; 40:107–27.10.1159/000132171Search in Google Scholar PubMed
10 Yang F, Lim JB, McGill JR, Moore CM, Naylor SL, Van Bragt PH, et al. Human transferrin: cDNA characterization and chromosomal localization. Proc Natl Acad Sci USA 1984; 81:2752–6.10.1073/pnas.81.9.2752Search in Google Scholar PubMed PubMed Central
11 Maekawa M, Sudo K, Kanno T, Kotani K, Dey DC, Ishikawa J, et al. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes. Clin Chim Acta 1995; 235:41–57.10.1016/0009-8981(95)06014-1Search in Google Scholar
12 Sudo K, Maekawa M, Kanno T, Akizuki S, Magara T. Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles. Clin Biochem 1996; 29:165–9.10.1016/0009-9120(95)02029-2Search in Google Scholar
13 Maekawa M, Sudo K, Dey DC, Ishikawa J, Izumi M, Kotani K, et al. Genetic mutations of butyrylcholine esterase Identified from phenotypic abnormalities in Japan. Clin Chem 1997; 43:924–9.10.1093/clinchem/43.6.924Search in Google Scholar
14 La Du BN, Bartels CF, Nogueira CP, Arpagaus M, Lockridge O. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol 1991; 11:79–89.Search in Google Scholar
15 Eiberg H, Nielsen LS, Klausen J, Dahlen M, Kristensen M, Bisgaard ML, et al. Linkage between serum cholinesterase2(CHE2) and γ-crystalline gene cluster (CRYG):assignment to chromosome2. Clin Genet 1989; 35:313–21.10.1111/j.1399-0004.1989.tb02951.xSearch in Google Scholar PubMed
16 Chautard-Freire-Maia EA, Primo-Parmo SL, Picheth G, Lourenco MAC. The C5 isozyme of serum cholinesterase and adult weight. Hum Hered 1991; 41:330–9.10.1159/000154021Search in Google Scholar PubMed
17 Iuchi I. Abnormal pseudocholinesterase. Jpn J Human Genet 1982; 27:95–101.10.1007/BF01993897Search in Google Scholar PubMed
18 Yoshida A, Motulsky AG. A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity. Am J Hum Genet 1969; 21:486–98.Search in Google Scholar
19 Harris H, Robson EB, Len-Bott AMG, Thornton JA. Evidence for non-allelism between genes affecting human serum cholinesterase. Nature 1963; 200:1185–7.10.1038/2001185a0Search in Google Scholar PubMed
20 Harris H, Hopkinson DA, Robson EB, Whittaker M. Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann Hum Genet (Lond) 1963; 26:359–82.10.1111/j.1469-1809.1963.tb01335.xSearch in Google Scholar PubMed
21 Neitlich HW. Increased plasma cholinesterase activity and succinyl-choline resistance: a genetic variant. J Clin Invest 1966; 45:380–7.10.1172/JCI105353Search in Google Scholar PubMed PubMed Central
22 Arpagaus M, Kott M, Vatsis KP, Bartels CF, La Du BN, Lockridge O. Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry 1990; 29:124–31.10.1021/bi00453a015Search in Google Scholar PubMed
23 Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE. Complete amino acid sequence of human serum cholinesterase. J Biol Chem 1987; 262:549–57.10.1016/S0021-9258(19)75818-9Search in Google Scholar
24 Masson P, Chatonnet A, Lockridge O. Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant(CHE2). FEBS 1990; 262:115–8.10.1016/0014-5793(90)80167-HSearch in Google Scholar
25 Sugimori T. Shortened action of succinylcholine in individuals with cholinesterase C5 Isozyme. Can Anaesth Soc J 1986; 33:321–7.10.1007/BF03010744Search in Google Scholar
26 Maekawa M, Sudo K, Kanno T. A simple staining method to detect serum cholinesterase activity. Clin Chim Acta 1987; 164:241–2.10.1016/0009-8981(87)90077-5Search in Google Scholar
27 Kotani K, Maekawa M, Hara K, Kanno T. Clinical significance of serum cholinesterase concentrations determined by enzyme-linked immunosorbent assay (ELISA). Jpn J Clin Pathol 1996; 44:965–9.Search in Google Scholar
28 Itoh Y, Fukamachi I, Hashimoto H, Hachisu T, Kawai T. Enzyme-linked immunosorbent assay for serum pseudocholinesterase. Clin Chim Acta 1992; 207:11–8.10.1016/0009-8981(92)90146-HSearch in Google Scholar
29 Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74:1245–9.10.1073/pnas.74.3.1245Search in Google Scholar PubMed PubMed Central
30 McGuire MC, Nogueira CP, Bartels CF, Lightstone H, Hajra H, Van der Spek AFL, et al. Identification of the structural mutation responsible for the dibuaine-resistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci USA 1989; 86:953–7.10.1073/pnas.86.3.953Search in Google Scholar PubMed PubMed Central
31 Nagai K, Sakata S, Kametani M, Gomi K, Tokimitsu N, Miura K. Familiar hypercholinesterasemia. A case report. Jpn J Med 1986; 25:313–6.10.2169/internalmedicine1962.25.313Search in Google Scholar PubMed
32 Scott EM, Powers RF. Properties of the C5 variant form of human serum cholinesterase. Am J Hum Genet 1974; 26:189–94.Search in Google Scholar
33 Masson P. Molecular heterogeneity of human plasma cholinesterase. American Chemical Society. 3rd International Meeting on Cholinesterase, 1990: 42–7.Search in Google Scholar
34 Ohkawa J, Furuya I, Tabata S, Saeki S, Oimomi T, Baba S. Chemical characterization of C5 cholinesterase isozyme. Chem Enzyme 1988; 40(Suppl 1):37–8.Search in Google Scholar
35 Rubinstein HM, Dietz AA, Lubrano T. E1k, another quantitative variant at cholinesterase locus 1. J Med Genet 1978; 15:27–9.10.1136/jmg.15.1.27Search in Google Scholar PubMed PubMed Central
36 Bartels CF, Jensen FS, Lockridge O, van der Spek AFL, Rubinstein HM, Lubrano T, et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992; 50:1086–103.Search in Google Scholar
37 Izumi M, Maekawa M, Kanno T. Butyrylcholinesterase K-variant in Japan: frequency of allele and associated enzyme activity in serum. Clin Chem 1994; 40:1606–7.10.1093/clinchem/40.8.1606aSearch in Google Scholar
38 Altamirano CV, Bartels CF, Lockridge O. The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme. J Neurochem 2000; 74:869–77.10.1046/j.1471-4159.2000.740869.xSearch in Google Scholar PubMed
© Walter de Gruyter
